Zacks Analyst Blog Highlights Exxon Mobil, T-Mobile US, Intuitive Surgical, Texas Instruments and Infosys | Techy Kings

[ad_1]

For immediate release

Chicago, IL – 2022 November 1 – Zacks.com publishes a list of stocks covered by analysts’ blogs. Each day, Zacks Equity Research analysts discuss the latest news and events affecting stocks and financial markets. Recently Blogged Stocks: Exxon Mobil Corp. XOM, T-Mobile US, Inc. TMUS, Intuitive Surgical, Inc. ISRG, Texas Instruments Inc. TXN and Infosys Ltd. INFY.

Here are the highlights from Monday’s analyst blog:

Top stock reports for ExxonMobil, T-Mobile and Intuitive Surgical

Zacks Research Daily presents the best research findings from our team of analysts. Today’s Research Daily has new research reports on 16 major stocks, including Exxon Mobil Corp., T-Mobile US, Inc. and Intuitive Surgical, Inc. These research reports have been selected from around 70 published by our analyst team. today.

You can all of today’s research reports can be found here >>>

Shares from Exxon Mobil. has outperformed the Zacks Oil and Gas – Integrated – International industry (+69.3% vs. +41.6%) over the past year. The company’s bellwether status and optimal integrated capital structure, which has historically delivered industry-leading returns, make it a relatively lower-risk energy sector.

Since 2015 Exxon Mobil has made more than 30 discoveries in Guyana. ExxonMobil is also active in the productive Permian Basin, where it expects to produce oil in 2022. to increase the production volume by 25 percent. belonging to the industry. XOM recently reported strong third-quarter earnings due to higher prices and production and strong refining margins.

However, the company is constantly burdened with ever-increasing costs, which has negatively impacted earnings. Also, an aggressive capital budget remains a headwind for the company. Therefore, stocks require a cautious stance.

(You can read the full Exxon Mobil investigation report here >>>)

Shares from T-Mobile has outperformed the Zacks Wireless National industry (+28.2% vs. -13.8%) over the past year. The company reported relatively modest 2022 third quarter results, and industry-leading postpaid and broadband customer growth, driven by a superior 5G network and customer focus. Decommissioning of Sprint’s customer network is expected to be completed by the end of the year.

T-Mobile has expanded its 5G footprint by introducing 5G home internet services in several states. T-Mobile has raised guidance for 2022 based on good demand trends.

However, it operates in a highly competitive and nearly saturated US telecommunications market, which limits its growth potential to some extent. Several promotional activities to attract additional customers further reduce its profitability. In addition, it uses a leasing strategy in order to attract customers and thereby take on credit risk. The problems of debt obligations also remain.

(You can read the full T-Mobil research report here >>>)

Intuitive surgery shares are down -30.7% over the past year, while the Zacks Medical – Instruments industry is down -33.5%. The company faces intense competition in the global MedTech space, and rising costs remain a concern. Nevertheless, the volume of da Vinci procedures in the first nine years of 2022 months, and this trend is likely to continue in the coming quarter.

Intuitive Surgical’s revenue growth during the quarter under review reflected increases in revenue from procedures, system placement and services across all markets. Management, a strong US dollar, lingering supply chain issues and inflation are weighing on operating margins.

Despite this challenging environment, Intuitive Surgical saw healthy customer demand for its products during the quarter under review. A stable liquidity position is an additional plus.

(You can read the full Intuitive Surgery study report here >>>)

Other noteworthy reports we have today include Texas Instruments Inc. and Infosys Ltd.

Why haven’t you looked at Zacks Top Stocks?

Our Top 5 Strategies Undercut the S&P’s Impressive +28.8% Gain in 2021 Surprisingly, they have grown +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today, you can access their live selections without any fees or obligations.

See Free Stock >>

Media contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future performance. Any investment has the potential for loss. This material is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that any investment in the securities, companies, sectors or markets identified and described has been or will be profitable. All information is current as of the date herein and is subject to change without notice. Any opinion or opinion expressed may not reflect the views of the company as a whole. Zacks Investment Research does not engage in investment banking, market making, or any securities asset management activities. These returns are derived from hypothetical portfolios consisting of stocks with a Zacks Rank = 1 that have been rebalanced monthly with non-zero transaction costs. It is not the return of actual stock portfolios. The S&P 500 is an unmanaged index. Please visit https://www.zacks.com/performance for information on the performance numbers presented in this press release.

Want the latest recommendations from Zacks Investment Research? Today you can download the 7 best promotions for the next 30 days. Click to get this free report

Texas Instruments Incorporated (TXN): Free Stock Analysis Report

Exxon Mobil Corporation (XOM): Free Stock Analysis Report

Infosys Limited (INFY): Free Stock Analysis Report

Intuitive Surgical, Inc. (ISRG): Free stock analysis report

TMobile US, Inc. (TMUS): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

[ad_2]

Source link